Statistics
Publications
2
Citations
57
H-Index
2
Active since
2018
Kun-Ching Lee is an author at Taipei Medical University Hospital specializing in nf-κb signaling, molecular oncology, and carcinogenesis.
Publications per year
2018–2018
2
2
Amentoflavone Inhibits Hepatocellular Carcinoma Progression Through Blockage of ERK/NF-ĸB Activation
Kun-Ching Lee, Wei-Ting Chen, Yu‐Chang Liu et al. · In Vivo · 2018 · 36 citations · Full text
Medicine, Oncology, Pharmacology +17
Amentoflavone Inhibits ERK-modulated Tumor Progression in Hepatocellular Carcinoma In Vitro
Kun-Ching Lee, Jai-Jen Tsai, Chih‐Wei Tseng et al. · In Vivo · 2018 · 21 citations · Full text
Medicine, Oncology, Pharmacology +14
1–2 of 2